The Asia Pacific Bioimpedance Analyzers Market would witness market growth of 10.0% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 90,242 Units, showcasing a growth of 2.6% (2019-2022).
Changing modern living standards can lead to hazardous behaviors, such as increased junk food consumption, mobility automation, and sedentary work environments. Consequently, these factors contribute to increased lifestyle-related diseases such as obesity, diabetes, hypertension, etc. As a result, these factors could increase bioimpedance analyzer acceptance due to the rising need for accurate assessment of individual muscle, bone, and fats, propelling the market's growth.
Bioimpedance analyzers are commonly used to assess body composition, including muscle mass, measurements of body fat percentage, and overall hydration levels. This application is prevalent in the fitness and wellness industries. These analyzers are also used in clinical settings for monitoring patients with conditions such as heart failure, edema, and renal disease. They can provide critical data on a patient's fluid balance and nutritional status. The fitness and sports industries have significantly used bioimpedance analyzers to track body composition changes in athletes and fitness enthusiasts. The demand for these devices has grown as more people prioritize health and fitness.
China has witnessed a significant increase in obesity rates, especially in urban areas. These analyzers play a crucial role in assessing and managing obesity by providing data on body composition, including body muscle mass, fat percentage, and hydration levels. According to the National Library of Medicine, in a survey of 15 770 094 eligible participants (median age 40 years; mean BMI 24.1 kg/m2; 52.8% male) 34.8% were overweight and 14.1% were obese by Chinese BMI classification. Overweight and obesity were more prevalent in male than female participants. The prevalence of assessed complications was higher in participants with overweight/obesity versus those with normal BMI. Thus, the factors mentioned above boost market expansion in this region.
The China market dominated the Asia Pacific Bioimpedance Analyzers Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $85.2 million by 2030. The Japan market is exhibiting a CAGR of 9.3% during (2023 - 2030). Additionally, The India market would experience a CAGR of 10.6% during (2023 - 2030).
Based on Modality, the market is segmented into Wireless, and Wired. Based on Product, the market is segmented into Multi-frequency, Single-frequency, and Others. Based on Application, the market is segmented into Segmental Body Measurement, and Whole-Body Measurement. Based on Usage Type, the market is segmented into Professional Grade, and Consumer Grade. Based on End User, the market is segmented into Fitness Clubs & Wellness Centers, Hospitals & Clinics, Home Users, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Bioimpedance Analyzers Market is Predict to reach $1.1 Billion by 2030, at a CAGR of 9.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include OMRON Corportion, Tanita Corporation, Inbody Co., Ltd., RJL Systems, SECA GMBH & Co. KG, Maltron International Limited, Selvas Healthcare, Fook Tin Technologies Ltd., Bodystat Ltd. and Charder Electronics Co. Ltd.
By Modality (Volume in Units, USD Million, 2019-2030)
By Product (Volume in Units, USD Million, 2019-2030)
By Application (Volume in Units, USD Million, 2019-2030)
By Usage Type (Volume in Units, USD Million, 2019-2030)
By End User (Volume in Units, USD Million, 2019-2030)
By Country (Volume in Units, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
